Gregory Odle Sells 8,433 Shares of OrthoPediatrics (NASDAQ:KIDS) Stock

OrthoPediatrics Corp. (NASDAQ:KIDS) insider Gregory Odle sold 8,433 shares of the business’s stock in a transaction on Monday, March 16th. The stock was sold at an average price of $17.25, for a total transaction of $145,469.25. Following the transaction, the insider directly owned 187,735 shares of the company’s stock, valued at approximately $3,238,428.75. This represents a 4.30% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

OrthoPediatrics Price Performance

KIDS traded up $0.10 during midday trading on Tuesday, hitting $17.21. The company had a trading volume of 197,133 shares, compared to its average volume of 152,452. OrthoPediatrics Corp. has a twelve month low of $15.28 and a twelve month high of $26.40. The company has a market capitalization of $435.07 million, a PE ratio of -10.18 and a beta of 1.07. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.65 and a current ratio of 5.55. The firm’s 50-day simple moving average is $17.74 and its 200-day simple moving average is $17.97.

OrthoPediatrics (NASDAQ:KIDS) last issued its quarterly earnings results on Thursday, February 26th. The company reported ($0.26) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.37) by $0.11. OrthoPediatrics had a negative net margin of 16.77% and a negative return on equity of 6.70%. The business had revenue of $61.61 million during the quarter, compared to analyst estimates of $61.27 million. Equities research analysts predict that OrthoPediatrics Corp. will post -0.93 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

KIDS has been the topic of a number of analyst reports. Canaccord Genuity Group started coverage on OrthoPediatrics in a research note on Wednesday, December 10th. They issued a “buy” rating and a $24.00 price target on the stock. Truist Financial lifted their price objective on shares of OrthoPediatrics from $19.00 to $20.00 and gave the stock a “hold” rating in a research note on Monday, March 2nd. Weiss Ratings restated a “sell (e+)” rating on shares of OrthoPediatrics in a research report on Thursday, January 22nd. Needham & Company LLC increased their target price on OrthoPediatrics from $26.00 to $30.00 and gave the stock a “buy” rating in a research note on Friday, February 27th. Finally, BTIG Research boosted their price target on OrthoPediatrics from $23.00 to $24.00 and gave the company a “buy” rating in a report on Friday, February 27th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $24.67.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the stock. Russell Investments Group Ltd. raised its stake in shares of OrthoPediatrics by 433.1% during the 3rd quarter. Russell Investments Group Ltd. now owns 1,402 shares of the company’s stock worth $26,000 after purchasing an additional 1,139 shares in the last quarter. Northwestern Mutual Wealth Management Co. grew its stake in shares of OrthoPediatrics by 5,226.5% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 2,610 shares of the company’s stock valued at $46,000 after buying an additional 2,561 shares in the last quarter. Caption Management LLC acquired a new position in OrthoPediatrics during the third quarter worth $54,000. BNP Paribas Financial Markets increased its holdings in OrthoPediatrics by 60.2% during the third quarter. BNP Paribas Financial Markets now owns 3,288 shares of the company’s stock worth $61,000 after buying an additional 1,235 shares during the last quarter. Finally, State of Wyoming raised its position in OrthoPediatrics by 189.7% during the fourth quarter. State of Wyoming now owns 6,822 shares of the company’s stock worth $121,000 after acquiring an additional 4,467 shares in the last quarter. Institutional investors and hedge funds own 69.05% of the company’s stock.

About OrthoPediatrics

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.